Generic name: pramipexole dihydrochloride
Dosage form: tablet, extended release
Drug class:Dopaminergic antiparkinsonism agents
Medically reviewed by Drugs.com. Last updated on Feb 1, 2022.
On This Page
- Indications and Usage
- Dosage and Administration
- Dosage Forms and Strengths
- Contraindications
- Warnings and Precautions
- Adverse Reactions/Side Effects
- Drug Interactions
- Use In Specific Populations
- Overdosage
- Description
- Clinical Pharmacology
- Nonclinical Toxicology
- Clinical Studies
- How Supplied/Storage and Handling
- Patient Counseling Information
Indications and Usage for Pramipexole ER Tablets
Pramipexole dihydrochloride extended- release tablets are indicated for the treatment of Parkinson's disease.
Pramipexole ER Tablets Dosage and Administration
General Dosing Considerations
Pramipexole dihydrochloride extended- release tablets are taken orally once daily, with or without food.
Pramipexole dihydrochloride extended- release tablets must be swallowed whole and must not be chewed, crushed, or divided.
If a significant interruption in therapy with pramipexole dihydrochloride extended- release tablets has occurred, re-titration of therapy may be warranted.
